About Us - Overview

The Charité Research Organisation (CRO) is a Contract Research Organization that has been established with one objective in mind - to better serve the unique needs of the early clinical development community than any organization before it.

Based in Berlin, at the very heart of Europe, the CRO was founded in collaboration with Berlin's famous Charité University Hospital. This relationship fosters a level of cooperation with centers of clinical excellence that we think is unique in the industry.

Indeed, we believe the CRO offers a whole new approach to the concept of partnering with centers of clinical excellence to facilitate access to patients, clinical expertise and specialist methodologies in support of early clinical development programs.

Founded in 1710, the Charité sees in excess of 120,000 in-patients per year and a further 900,000 on an out-patient basis, making it one of the single largest and most diverse patient resources within Europe. It is also one of Europe's premier centers of research excellence with over 100 million euro in research funding each year.

Run independently of the Charité administration, as a company with it's own dedicated management, staff and administration, the CRO provides complete early development solutions from "First-In-Man" through Phase II. Clinical pharmacology studies are performed in our own, dedicated, ICH GCP compliant research unit located within the central campus of the hospital.

Complete early development programs are undertaken at the CRO, with a seamless transition from the first healthy volunteer studies to early work in patients - a transition helped enormously by the patient resources on hand. Of course, our capabilities extend well beyond basic clinical pharmacology. The widest possible range of pharmacodynamic studies can be performed - supported by the methodological excellence at our disposal within the Charité network.